ASH 2023: MRD Highlights in BioPharma Drug Development

Read More

Deep sustained response to daratumumab monotherapy associated with T-cell expansion in triple refractory myeloma

Usmani et al.
Experimental Hematology & Oncology
Papers
February 2018
Authors and Affiliates
Saad Z. Usmani1, Imran Khan2, Christopher Chiu3, David Foureau1, Lawrence J. Druhan1, Katherine Rigby1, Tineke Casneuf4, and A. Kate Sasser3 1Levine Cancer Institute/Carolinas Health Care System, 1021 Morehead Medical Drive, Charlotte, NC 28204 USA., 2Janssen Research & Development, LLC, Raritan, NJ USA., 3Janssen Research & Development, LLC, Spring House, PA USA., 4Janssen Research & Development, Beerse, Belgium.